Ovid Therapeutics Inc
1OT
Company Profile
Business description
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Contact
441 Ninth Avenue
14th Floor
New YorkNY10001
USAT: +1 646 661-7661
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
23
Stocks News & Analysis
stocks
AMD earnings: Data center demand still looks quite strong to us
AMD has the components to target $100 billion of AI revenue in the next few years.
stocks
PayPal earnings: Growth slows, new CEO appointed
We expect to lower our fair value estimate of PayPal stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,154.90 | 49.70 | -0.54% |
| CAC 40 | 8,275.77 | 13.61 | 0.16% |
| DAX 40 | 24,530.19 | 72.85 | -0.30% |
| Dow JONES (US) | 49,278.32 | 37.33 | 0.08% |
| FTSE 100 | 10,363.92 | 38.42 | -0.37% |
| HKSE | 26,885.24 | 37.92 | 0.14% |
| NASDAQ | 22,904.58 | 350.61 | -1.51% |
| Nikkei 225 | 53,818.04 | 475.32 | -0.88% |
| NZX 50 Index | 13,444.02 | 23.27 | -0.17% |
| S&P 500 | 6,848.62 | 69.19 | -1.00% |
| S&P/ASX 200 | 8,889.20 | 38.60 | -0.43% |
| SSE Composite Index | 4,075.92 | 26.29 | -0.64% |